INTELLIPHARMACEUTICS INTERNATIONAL INC. Shareholders' Equity
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Shareholders' Equity of -$12.88 million as of 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-02-06
- 2018-11-30: Stockholders' Equity Attributable to Parent 4.10M CAD.
- 2017-11-30: Stockholders' Equity Attributable to Parent 386.38K CAD.
- 2017-05-31: Stockholders' Equity Attributable to Parent 806.32K CAD.
- 2017-02-28: Stockholders' Equity Attributable to Parent 871.32K CAD.
CAD
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2018-11-30 | 4.10M CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | 386.38K CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | 806.32K CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | 871.32K CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | 1.12M CAD 20-F · filed 2019-03-04 |
| 2016-05-31 | -1.91M CAD 6-K · filed 2017-07-11 |
| 2016-02-29 | -1.01M CAD 6-K · filed 2017-04-12 |
| 2015-11-30 | -137.69K CAD 20-F · filed 2019-03-04 |
| 2014-11-30 | 4.91M CAD 20-F · filed 2018-03-01 |
| 2013-11-30 | -5.96M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-08-31 | -$12.88M 6-K · filed 2023-10-16 | |
| 2023-05-31 | -$12.88M 6-K · filed 2023-10-16 | -$10.99M 6-K · filed 2023-09-26 |
| 2023-02-28 | -$10.93M 6-K · filed 2023-09-26 | |
| 2022-11-30 | -$10.58M 20-F/A · filed 2024-02-06 | |
| 2022-08-31 | -$10.15M 6-K · filed 2022-10-14 | |
| 2022-05-31 | -$9.86M 6-K · filed 2023-10-16 | |
| 2022-02-28 | -$9.02M 6-K · filed 2023-09-26 | |
| 2021-11-30 | -$8.16M 20-F/A · filed 2024-02-06 | |
| 2021-08-31 | -$6.17M 6-K · filed 2022-10-14 | |
| 2021-05-31 | -$5.03M 6-K · filed 2022-07-21 | |
| 2021-02-28 | -$7.19M 6-K · filed 2022-04-14 | |
| 2020-11-30 | -$6.31M 20-F/A · filed 2024-02-06 | |
| 2020-08-31 | -$4.68M 6-K · filed 2021-10-15 | |
| 2020-05-31 | -$5.81M 6-K · filed 2021-07-15 | |
| 2020-02-29 | -$4.83M 6-K · filed 2021-04-14 | |
| 2019-11-30 | -$3.69M 20-F/A · filed 2024-02-06 | |
| 2019-08-31 | -$2.41M 6-K · filed 2020-10-15 | |
| 2019-05-31 | -$1.00M 6-K · filed 2020-07-15 | |
| 2019-02-28 | $906.59K 6-K · filed 2020-05-29 | |
| 2018-11-30 | $4.10M 20-F/A · filed 2022-05-09 | |
| 2018-08-31 | -$4.96M 6-K · filed 2019-10-11 | |
| 2018-05-31 | -$1.03M 6-K · filed 2019-07-10 | |
| 2018-02-28 | -$2.72M 6-K · filed 2019-04-15 | |
| 2017-11-30 | $386.38K 20-F · filed 2021-03-31 | |
| 2017-08-31 | -$792.77K 6-K · filed 2018-10-15 | |
| 2017-05-31 | $806.32K 6-K · filed 2018-07-24 | |
| 2016-11-30 | $1.12M 20-F · filed 2020-03-30 | |
| 2015-11-30 | -$137.69K 20-F · filed 2016-03-21 | |
| 2014-11-30 | $4.91M 20-F · filed 2016-03-21 | |
| 2014-02-28 | $6.90M 6-K · filed 2014-04-14 | |
| 2013-11-30 | -$5.96M 20-F · filed 2016-03-21 | |
| 2013-02-28 | -$2.65M 6-K · filed 2014-04-14 | |
| 2012-11-30 | -$1.77M 20-F · filed 2016-03-21 | |
| 2011-11-30 | -$3.09M 20-F · filed 2015-02-27 | |
| 2010-11-30 | $92.96K 20-F · filed 2014-02-18 | |
| 2009-11-30 | $4.63M 20-F/A · filed 2013-02-01 | |
| 2008-12-31 | -$583.08K 20-F · filed 2012-05-11 |